Home › Blog › Cord Blood Safety Study

Cord Blood Safety Study

Published on Sep 2, 2010

Congrats to Beike and Medistem for a well done safety study on expanded cord blood treatments in China for neurological disorders. Again, compared to the safety profile of common sledgehammer immune supressant drugs for conditions like Multiple Sclerosis., this therapy seems to be much safer. While a bigger dataset followed for longer periods would be nice, this paper seems to support the safety profile already published by our group and others showing that cell based therapy complications are generally less than the more traditional therapies they help replace.

Learn More About Regenexx^® Procedures

Request a digital booklet and more information to learn about alternatives to orthopedic surgery and the Regenexx patient experience.

We do not sell, or share your information to third party vendors. By submitting the form you agree that you've read and consent to our Privacy Policy.

Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile

If you have questions or comments about this blog post, please email us at [email protected]

NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.